Teachers Advisors’s Arbutus Biopharma ABUS Stock Holding History

Teachers Advisors’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$272K	Hold	75,945	–	–	﹤0.01%	2755
2018 Q4	$291K	Hold	75,945	–	–	﹤0.01%	2720
2018 Q3	$718K	Buy	75,945 +8,428	+12%	+$83.7K	﹤0.01%	2478
2018 Q2	$493K	Buy	+67,517	New	+$402K	﹤0.01%	2658

Other funds holding ABUS

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Teachers Advisors's ABUS Position: Q1 2019 in Review

Teachers Advisors held its Arbutus Biopharma (ABUS) position steady in Q1 2019 at 75,945 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Teachers Advisors first reported a position in ABUS in Q2 2018 and has held it in 4 quarters since. The position peaked at $718K in Q3 2018. 72 funds tracked by Wall St. Rank hold ABUS as of Q1 2019.

Teachers Advisors held 75,945 shares of Arbutus Biopharma worth $272K as of Q1 2019.
Teachers Advisors left its Arbutus Biopharma share count unchanged in Q1 2019.
Arbutus Biopharma made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2755 holding.
Teachers Advisors first reported a position in Arbutus Biopharma in Q2 2018 and has held it in 4 quarters since.
Teachers Advisors's Arbutus Biopharma position peaked at $718K in Q3 2018.
72 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.